Crescents in IgA nephropathy: making the step from prognostic risk factor to therapy target

Gabriel Stefan^{1

2}

Affiliations

Gabriel Stefan. Ren Fail. 2023.

. 2023;45(2):2236231.

doi: 10.1080/0886022X.2023.2236231. Epub 2023 Sep 19.

Gabriel Stefan^{1

2}

No abstract available

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Mortality in IgA Nephropathy: A Long-Term Follow-Up of an Eastern European Cohort.
Ștefan G, Zugravu A, Stancu S. Ștefan G, et al. Medicina (Kaunas). 2024 Jan 31;60(2):247. doi: 10.3390/medicina60020247. Medicina (Kaunas). 2024. PMID: 38399535 Free PMC article.

1. Di D, Liu L, Wang Y, et al. . Crescents proportions above 10% are associated with unfavorable kidney outcomes in IgA nephropathy patients with partial crescent formation. Ren Fail. 2023;45(1):1. - PMC - PubMed
1. Bellur SS, Roberts ISD, Troyanov S, et al. . Reproducibility of the oxford classification of immunoglobulin a nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort. Nephrol Dial Transplant. 2019;34(10):1681–2. doi: 10.1093/ndt/gfy337. - DOI - PubMed
1. Kitamura M, Almaani S, Challa B, et al. . The diagnostic conundrum of glomerular crescents with IgA deposits. Kidney Int Rep. 2023;8(3):507–518. doi: 10.1016/j.ekir.2022.12.024. - DOI - PMC - PubMed
1. Ştefan G, Ismail G, Stancu S, et al. . Validation study of oxford classification of IgA nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining. Pathol Int. 2016;66(8):453–459. doi: 10.1111/pin.12442. - DOI - PubMed
1. Stefan G, Stancu S, Zugravu A, et al. . Towards a simplified renal histopathological prognostic score in glomerular nephropathies. Histopathology. 2020;77(6):926–935. Dec doi: 10.1111/his.14175. - DOI - PubMed